Try our beta test site
45 studies found for:    "Diabetes Insipidus" [DISEASE]
Show Display Options
Rank Status Study
21 Completed Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
Conditions: Syndrome of Inappropriate ADH (SIADH) Secretion;   Hyponatremia
Intervention: Drug: satavaptan (SR121463B)
22 Recruiting Tracking Neurodegeneration in Early Wolfram Syndrome
Conditions: Type 1 Diabetes;   Diabetes Insipidus;   Diabetes Mellitus;   Wolfram Syndrome
Intervention:
23 Completed Vasopressin Deficiency in Hemorrhagic Shock
Condition: Body Response to Trauma
Intervention: Other: Phlebotomy
24 Completed
Has Results
V2 Receptor Effects on Fluid Regulation and Performance
Conditions: Electrolyte Imbalance;   Hyponatremia;   Hypernatremia
Intervention: Drug: V2R (Vasopressin 2 receptor)
25 Unknown  Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin
Conditions: Chronic Hepatitis C;   Chronic Hepatitis B;   Biopsy;   Hemodialysis
Intervention: Procedure: Percutaneous liver biopsy
26 Recruiting Early Use of Vasopressin in Post-Fontan Management
Conditions: Circulatory Perfusion Disorder;   Congenital Heart Disease;   Single-ventricle
Interventions: Drug: Vasopressin, Arginine;   Drug: Placebos
27 Completed Hemodynamic Effects of Vasopressin in Early Septic Shock Stage
Condition: Septic Shock
Intervention: Drug: Vasopressin infusion
28 Completed Desmopressin in Cardiac Surgery
Conditions: Hemorrhage;   Blood Loss, Surgical;   Postoperative Hemorrhage
Interventions: Drug: Desmopressin (DDAVP);   Drug: Placebo
29 Completed Vasopressin in Traumatic Hemorrhagic Shock Study
Conditions: Shock;   Hypovolemia;   Hemorrhagic Shock
Interventions: Drug: Vasopressin;   Drug: Saline placebo
30 Terminated A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia
Conditions: Hyponatremia;   Inappropriate ADH Syndrome
Interventions: Drug: Satavaptan;   Drug: placebo
31 Recruiting Wolfram Syndrome International Registry and Clinical Study
Conditions: Wolfram Syndrome;   Diabetes Mellitus;   Optic Nerve Atrophy;   Deafness;   Diabetes Insipidus;   Ataxia
Intervention:
32 Recruiting Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome
Conditions: Healthy;   Polyuria-polydipsia Syndrome
Intervention:
33 Completed Copeptin in Differentiation of Polyuria and Polydipsia
Conditions: Polyuria;   Polydipsia
Intervention:
34 Completed Study of Copeptin as a Diagnostic Marker for Acute Pancreatitis
Conditions: Acute Pancreatitis;   Pancreatitis
Intervention: Other: No intervention
35 Completed Efficacy Study of Water Drinking on PKD Progression.
Conditions: Autosomal Dominant Polycystic Kidney Disease.;   Disease Progression
Intervention:
36 Terminated Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older
Condition: Nocturia
Interventions: Drug: Desmopressin;   Drug: Fesoterodine
37 Not yet recruiting Treatment of Wolfram Syndrome Type 2 With the Chelator Deferiprone and Incretin Based Therapy
Conditions: Diabetes Mellitus;   Iron Metabolism Disorders;   Gastroduodenal Ulcer;   Optic Atrophy;   Sensorineural Hearing Loss;   Platelet Dysfunction
Interventions: Drug: Deferiprone;   Drug: Acetylcysteine;   Drug: Sitagliptin and Metformin
38 Recruiting A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome
Conditions: Wolfram Syndrome;   Diabetes Mellitus;   Optic Nerve Atrophy;   Ataxia
Intervention: Drug: dantrolene sodium
39 Unknown  GLP Analogs for Diabetes in Wolfram Syndrome Patients
Conditions: Diabetes Mellitus Associated With Genetic Syndrome;   Wolfram Syndrome
Intervention: Drug: Exenatide
40 Completed Copeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water Homeostasis
Condition: Pituitary Adenoma
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-45) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.